What’s new in the PerkinElmer reagent portfolio ?
Everyday, PerkinElmer’s team put its scientific expertise to provide solutions and solve problems faced by scientists around the world. After months of diligently work, we are excited to announce the launch of new products this month !
New products using the HTRF® technology
The phospho-protein assays portfolio is enriched with 4 new HTRF kits !
4 new assays have been developed to investigate the ATR/CHK1 pathway:
New products using the AlphaLISA® technology
4 new alphaLISA assays were added to detect AAV capsid
New products using the AlphaLISA® SureFire® Ultra™ technology
15 new assays were added to the Cellular Phospho-Protein assays portfolio !
- Androgen Receptor, Total
- Aurora A, Phospho-Thr288
- Aurora A, Total
- Aurora B, Phospho-Thr232
- Aurora B, Total
- CDK2, Phospho-Thr160
- HSP27, Phospho-Ser15
- HSP27, Phospho-Ser78
- HSP27, Phospho-Ser82
- HSP27, Total
- SL76, Phospho-Tyr145
- Tau, Phospho-Ser396
- Tau, Total
- CDK1, Phospho-Thr14 +, Total CDK1
- CDK1, Phospho-Tyr15+, Total CDK1